Claritas Pharmaceuticals Inc V.CLAS.H

The stars are aligning for KLY

[Seagrind]

Well, it has taken a little longer than any of us had expected, but I think we are VERY near our partnership deal announcement. It looks like they wanted to clear up some of their liabilities before entering into a new agreement, ok, check. It also seems as if they wanted to get their patants locked down as well for US and Europe, ok, check. Now we are right on the door step of their negotiated deal deadline with Talent and we have KLY's CSO give a talk along side TBP, GW Pharma and and others. The CSO's talk as per the ICBD3 agenda is as follows:

"CBD for GVHD: Experience from an FDA Guided CBD Drug Development Program "Graft versus host disease (GVHD) is a serious and potentially life-threatening complication of allogeneic bone marrow transplantations. GVHD occurs when the donor's immune system attacks the patient's organs. It's incidence and mortality rates are very high. For the last eight years, we have performed various phase 2 clinical trials with Cannabidiol (CBD) for both the prevention and treatment of acute GVHD and demonstrated its safety and efficacy with outstanding results. We have approached the FDA various times and gotten guidelines for development. During this session, I would like to share our clinical results and experience with the FDA for CBDbased drug development."

Time to talk about these results on a global stage and unveil the path forward. NR tomorrow morning would make sence to me so our CSO can talk to the path forward as she most certainly will be asked. Or, release Friday once one eyes and hears are on KLY's phenomenal results. I'm going to go with tomorrow AM, but who knows. What I do know is that I won't be selling any shares anytime soon. GL